\-\ Texto\\:\\ \ \(0\)\
\-\ non\\-contributory\ \(73\)\
\-\ radiation\\ and\\ chemotherapy\ \(19\)\
\-\ expansile\\ mass\\ lesion\\ involving\\ the\\ splenium\\ of\\ the\\ corpus\\ callosum\\.\\ \\ the\\ mass\\ enhances\\ homogeneously\\ and\\ produces\\ a\\ moderate\\ amount\\ of\\ surrounding\\ vasogenic\\ edema\\.\\ \\ the\\ mass\\ is\\ not\\ particularly\\ bright\\ on\\ flair\\ and\\ t2\\.\ \(0\)\
\-\ diffuse\\ large\\ b\\-cell\\ lymphoma\ \(1\)\
\-\ \\â\\€\\¢\\ glioma\\ \\(astrocytoma\\,\\ oligodendroglioma\\,\\ oligoastrocytoma\ \(0\)\
\-\ \\â\\€\\¢\\ primary\\ cns\\ lymphoma\ \(0\)\
\-\ \\â\\€\\¢\\ tumefactive\\ demyelination\ \(0\)\
\-\ \\Â\\»\\ ms\\,\\ adem\\,\\ marchiafava\\-bignami\\ disease\\,\\ etc\\.\ \(0\)\
\-\ \\â\\€\\¢\\ infection\\ \\(abscess\\,\\ encephalitis\\,\\ ventriculitis\\)\ \(0\)\
\-\ \\â\\€\\¢\\ metastatic\\ disease\ \(13\)\
\-\ 58\\ year\\ old\\ man\\ with\\ 2\\ month\\ history\\ of\\ personality\\ changes\\ and\\ headache\\.\ \(1\)\
\-\ the\\ increased\\ cellularity\\ of\\ \\"small\\ round\\ blue\\ cell\\ tumors\\"\\ \\-\\ like\\ lymphoma\\ \\-\\ often\\ has\\ a\\ characteristic\\ imaging\\ appearance\\ of\\ high\\ attenuation\\ on\\ pre\\-contrast\\ ct\\,\\ low\\ signal\\ on\\ t1\\ and\\ t2\\ mr\\,\\ and\\ low\\ adc\\/high\\ signal\\ on\\ dwi\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ marchiafava\\-bignami\\:\\ 0\\.0638805682896123\ \(0\)\
\-\ adc\\/high\\:\\ 0\\.0638805682896123\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.05677588230419884\ \(0\)\
\-\ ventriculitis\\:\\ 0\\.05591960967607528\ \(0\)\
\-\ oligoastrocytoma\\:\\ 0\\.05383495697714933\ \(0\)\
\-\ lymphoma\\:\\ 0\\.053091274660640994\ \(0\)\
\-\ personality\\:\\ 0\\.04719516906501777\ \(0\)\
\-\ cellularity\\:\\ 0\\.04719516906501777\ \(0\)\
\-\ pre\\-contrast\\:\\ 0\\.04529397874278957\ \(0\)\
\-\ splenium\\:\\ 0\\.04475696445182058\ \(0\)\
\-\ demyelination\\:\\ 0\\.041159595710415574\ \(0\)\
\-\ blue\\:\\ 0\\.040851192707380815\ \(0\)\
\-\ tumefactive\\:\\ 0\\.039997692449001226\ \(0\)\
\-\ b\\-cell\\:\\ 0\\.03854355697463781\ \(0\)\
\-\ produces\\:\\ 0\\.038327231154712586\ \(0\)\
\-\ adem\\:\\ 0\\.037333020129252555\ \(0\)\
\-\ oligodendroglioma\\:\\ 0\\.03629605749417521\ \(0\)\
\-\ homogeneously\\:\\ 0\\.03613679005418408\ \(0\)\
\-\ t2\\:\\ 0\\.03505201114130945\ \(0\)\
\-\ encephalitis\\:\\ 0\\.03458309533428948\ \(0\)\
\-\ low\\:\\ 0\\.03443721815748405\ \(0\)\
\-\ 58\\:\\ 0\\.03421140479524926\ \(0\)\
\-\ vasogenic\\:\\ 0\\.033520751318406324\ \(0\)\
\-\ etc\\:\\ 0\\.033520751318406324\ \(0\)\
\-\ ms\\:\\ 0\\.03309437088345753\ \(0\)\
\-\ dwi\\:\\ 0\\.03289023409384379\ \(0\)\
\-\ signal\\:\\ 0\\.03265325116337361\ \(0\)\
\-\ particularly\\:\\ 0\\.031947820121030764\ \(0\)\
\-\ callosum\\:\\ 0\\.031773200182052055\ \(0\)\
\-\ cns\\:\\ 0\\.03168744324258103\ \(0\)\
\-\ bright\\:\\ 0\\.030958142331134017\ \(0\)\
\-\ corpus\\:\\ 0\\.030509769840423237\ \(0\)\
\-\ \\Â\\»\\:\\ 0\\.030509769840423237\ \(0\)\
\-\ expansile\\:\\ 0\\.030366272541175555\ \(0\)\
\-\ enhances\\:\\ 0\\.02924923862938383\ \(0\)\
\-\ like\\:\\ 0\\.028664536373948016\ \(0\)\
\-\ flair\\:\\ 0\\.028388975536344833\ \(0\)\
\-\ glioma\\:\\ 0\\.02791792604135211\ \(0\)\
\-\ round\\:\\ 0\\.026750394525820575\ \(0\)\
\-\ \\-\\:\\ 0\\.02654678925664295\ \(0\)\
\-\ characteristic\\:\\ 0\\.026210299947106323\ \(0\)\
\-\ amount\\:\\ 0\\.025858654723231973\ \(0\)\
\-\ mass\\:\\ 0\\.025836108846686183\ \(0\)\
\-\ attenuation\\:\\ 0\\.0248958048581597\ \(0\)\
\-\ moderate\\:\\ 0\\.024349255859484033\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.02404601593241519\ \(0\)\
\-\ tumors\\:\\ 0\\.023258814186018124\ \(0\)\
\-\ non\\-contributory\\:\\ 0\\.022869827595702007\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.022195259312614967\ \(0\)\
\-\ involving\\:\\ 0\\.021727588869589084\ \(0\)\
\-\ headache\\:\\ 0\\.021268010417143463\ \(0\)\
\-\ on\\:\\ 0\\.020982348184505163\ \(0\)\
\-\ surrounding\\:\\ 0\\.020356270031628734\ \(0\)\
\-\ radiation\\:\\ 0\\.020320661228712584\ \(0\)\
\-\ disease\\:\\ 0\\.020242573061097162\ \(0\)\
\-\ often\\:\\ 0\\.01975705469941777\ \(0\)\
\-\ mr\\:\\ 0\\.019675358492365465\ \(0\)\
\-\ t1\\:\\ 0\\.019626779248001765\ \(0\)\
\-\ abscess\\:\\ 0\\.019578523508219328\ \(0\)\
\-\ diffuse\\:\\ 0\\.018746430582429818\ \(0\)\
\-\ month\\:\\ 0\\.018576916962323258\ \(0\)\
\-\ primary\\:\\ 0\\.01834336422388186\ \(0\)\
\-\ infection\\:\\ 0\\.018000120101976862\ \(0\)\
\-\ changes\\:\\ 0\\.017746724465471455\ \(0\)\
\-\ appearance\\:\\ 0\\.017709467947352474\ \(0\)\
\-\ \\,\\:\\ 0\\.017655004272866568\ \(0\)\
\-\ edema\\:\\ 0\\.01751393832921225\ \(0\)\
\-\ high\\:\\ 0\\.016945985949831998\ \(0\)\
\-\ cell\\:\\ 0\\.016726381967981784\ \(0\)\
\-\ metastatic\\:\\ 0\\.015587749301565871\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.015218369837911718\ \(0\)\
\-\ increased\\:\\ 0\\.015148440447823592\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.014925721028856833\ \(0\)\
\-\ man\\:\\ 0\\.014644433645579704\ \(0\)\
\-\ imaging\\:\\ 0\\.014507781336634802\ \(0\)\
\-\ small\\:\\ 0\\.014265038292616801\ \(0\)\
\-\ large\\:\\ 0\\.013540162549500578\ \(0\)\
\-\ 2\\:\\ 0\\.013334090554424248\ \(0\)\
\-\ lesion\\:\\ 0\\.012612719028988802\ \(0\)\
\-\ has\\:\\ 0\\.011628260655755637\ \(0\)\
\-\ \\(\\:\\ 0\\.010469010525273341\ \(0\)\
\-\ not\\:\\ 0\\.008947961389434314\ \(0\)\
\-\ ct\\:\\ 0\\.008661620676753934\ \(0\)\
\-\ history\\:\\ 0\\.008552279258746982\ \(0\)\
\-\ and\\:\\ 0\\.007826478510096454\ \(0\)\
\-\ year\\:\\ 0\\.006928299052702281\ \(0\)\
\-\ old\\:\\ 0\\.006340105774364164\ \(0\)\
\-\ a\\:\\ 0\\.005747823214762337\ \(0\)\
\-\ \\)\\:\\ 0\\.005170562986328298\ \(0\)\
\-\ the\\:\\ 0\\.0050090320544791955\ \(0\)\
\-\ of\\:\\ 0\\.004221152202825668\ \(0\)\
\-\ is\\:\\ 0\\.004074570857860331\ \(0\)\
\-\ \\.\\:\\ 0\\.0015434580911889684\ \(0\)\
\-\ with\\:\\ 0\\.0008478563484774619\ \(0\)\
